• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Industry
    • Exhibits and Support & Visibility Opportunities
    • Industry Archives
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2025 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2025 Proffered Presentations

2025 Proffered Presentations

 

← Back to Previous Page

 

S215: MENINGIOMAS CAUSING BONY HYPEROSTOSIS HAVE A MORE SEVERE CLINICAL COURSE
Malcolm F McDonald1; A. Basit Khan, MD1; Andrew Chang, MD1; Collin English1; Eric A Goethe, MD1; Sricharan Gopakumar, MD1; Ali Jalali, MD, PhD1; Ganesh Rao, MD1; Arif Harmanci, PhD2; Akdes Harmanci, PhD1; Tiemo J Klisch, PhD1; Akash J Patel, MD1; 1Baylor College of Medicine; 2UT Health Science Center Houston

Meningiomas are the most common primary tumor of the brain and may elicit hyperostosis of the adjacent bone. Whether hyperostosis is related to reactive changes of the overlying bone or by invasion of the tumor itself is unclear. Here, we characterize the clinical differences of meningiomas with hyperostosis from those without hyperostosis. One-hundred and eighty-one primary, non-syndromic, non-radiation induced meningiomas were included (Fig.1A). Preoperative MRI and CT scans were reviewed by a fellowship trained neuroradiologist to identify presence of hyperostosis (Fig.1B-C) or bone invasion (Fig.1D-E). Clinical, radiographic, and surgical data were gathered for each patient. Sixty-six (36.5%) meningiomas had radiographic evidence of hyperostosis compared to 115 (63.5%) without. Patients with hyperostosis had more severe presentation with increased rates of emergency admissions (p=0.0320) and seizure presentation (p=0.0480) (Table 1). Hyperostotic tumors preferentially manifested in the convexity, parasagittal, olfactory groove, and sphenoid wing locations (p=0.004) (Table 1).  Radiographically, tumors with hyperostosis had higher rates of edema (p=0.0280), midline shift (p=0.010), non-homogeneous enhancement (p=0.001), T2 hyperechoic signal (p=0.001), and bone invasion (p<0.001) (Table 2). Patients with hyperostosis had increased estimated blood loss intraoperatively (p=0.006), longer time in the operating room (p=0.045), and higher rates of craniectomy and cranioplasty (p<0.001, p=0.001) (Table 3). In conclusion, meningiomas with hyperostosis is region specific, related to higher intraoperative complications and present with distinct radiographic features.

Figure 1

Table 1

Table 2

Table 3

 

← Back to Previous Page

Copyright © 2025 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved